Global Herpes Treatment Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	171 Pages	TechNavio	May, 2024	INF18930071

Best Price Guarantee
Price	from $2,500
Length	171 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF18930071

Global Herpes Treatment Market 2024-2028

Technavio has been monitoring the herpes treatment market and is forecast to grow by USD 1142.2 mn during 2023-2028, accelerating at a CAGR of 4.43% during the forecast period. Our report on the herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of herpes infection, large patient pool, and rising prevalence rate of shingles in older population.

Technavio's herpes treatment market is segmented as below:

By Product

Vaccination
Drug therapy

By Type

Herpes zoster
Herpes simplex

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emergence of novel therapies as one of the prime reasons driving the herpes treatment market growth during the next few years. Also, increasing focus on vaccine development and increasing research on developing safe treatment for herpes will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the herpes treatment market covers the following areas:

Herpes treatment market sizing
Herpes treatment market forecast
Herpes treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading herpes treatment market vendors that include AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., Bausch Health Companies Inc., CENTURION REMEDIES Pvt. Ltd., Cipla Inc., Eli Lilly and Co., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Zeelab Laboratories Ltd., and Zydus Lifesciences Ltd.. Also, the herpes treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Herpes Treatment Market 2018 - 2022; Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Vaccination - Market size and forecast 2023-2028; Chart on Vaccination - Market size and forecast 2023-2028 ($ million); Data Table on Vaccination - Market size and forecast 2023-2028 ($ million); Chart on Vaccination - Year-over-year growth 2023-2028 (%); Data Table on Vaccination - Year-over-year growth 2023-2028 (%); 6.4 Drug therapy - Market size and forecast 2023-2028; Chart on Drug therapy - Market size and forecast 2023-2028 ($ million); Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million); Chart on Drug therapy - Year-over-year growth 2023-2028 (%); Data Table on Drug therapy - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Herpes zoster - Market size and forecast 2023-2028; Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million); Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million); Chart on Herpes zoster - Year-over-year growth 2023-2028 (%); Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%); 7.4 Herpes simplex - Market size and forecast 2023-2028; Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million); Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million); Chart on Herpes simplex - Year-over-year growth 2023-2028 (%); Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape2023-2028 (%); Data Table on Market share By Geographical Landscape2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ million); Data Table on France - Market size and forecast 2023-2028 ($ million); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity By Geographical Landscape($ million); Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 AiCuris Anti infective Cures AG; AiCuris Anti infective Cures AG - Overview; AiCuris Anti infective Cures AG - Product / Service; AiCuris Anti infective Cures AG - Key offerings; 12.5 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; 12.6 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 12.7 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.8 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 12.9 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Maruho Co. Ltd.; Maruho Co. Ltd. - Overview; Maruho Co. Ltd. - Product / Service; Maruho Co. Ltd. - Key news; Maruho Co. Ltd. - Key offerings; 12.12 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.14 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 12.15 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; 12.16 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus; 12.17 Zydus Lifesciences Ltd.; Zydus Lifesciences Ltd. - Overview; Zydus Lifesciences Ltd. - Business segments; Zydus Lifesciences Ltd. - Key news; Zydus Lifesciences Ltd. - Key offerings; Zydus Lifesciences Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Herpes Treatment Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Vaccination - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Vaccination - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Vaccination - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Vaccination - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Drug therapy - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Drug therapy - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Type - Market share 2023-2028 (%); Exhibits47: Data Table on Type - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Type; Exhibits49: Data Table on Comparison by Type; Exhibits50: Chart on Herpes zoster - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Herpes zoster - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Herpes zoster - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Herpes zoster - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Herpes simplex - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Herpes simplex - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Herpes simplex - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Herpes simplex - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Type ($ million); Exhibits59: Data Table on Market opportunity by Type ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on France - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on France - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: AbbVie Inc. - Overview; Exhibits110: AbbVie Inc. - Product / Service; Exhibits111: AbbVie Inc. - Key news; Exhibits112: AbbVie Inc. - Key offerings; Exhibits113: AiCuris Anti infective Cures AG - Overview; Exhibits114: AiCuris Anti infective Cures AG - Product / Service; Exhibits115: AiCuris Anti infective Cures AG - Key offerings; Exhibits116: Aurobindo Pharma Ltd. - Overview; Exhibits117: Aurobindo Pharma Ltd. - Product / Service; Exhibits118: Aurobindo Pharma Ltd. - Key offerings; Exhibits119: Cipla Inc. - Overview; Exhibits120: Cipla Inc. - Business segments; Exhibits121: Cipla Inc. - Key offerings; Exhibits122: Cipla Inc. - Segment focus; Exhibits123: Eli Lilly and Co. - Overview; Exhibits124: Eli Lilly and Co. - Product / Service; Exhibits125: Eli Lilly and Co. - Key news; Exhibits126: Eli Lilly and Co. - Key offerings; Exhibits127: Fresenius SE and Co. KGaA - Overview; Exhibits128: Fresenius SE and Co. KGaA - Business segments; Exhibits129: Fresenius SE and Co. KGaA - Key news; Exhibits130: Fresenius SE and Co. KGaA - Key offerings; Exhibits131: Fresenius SE and Co. KGaA - Segment focus; Exhibits132: Gilead Sciences Inc. - Overview; Exhibits133: Gilead Sciences Inc. - Product / Service; Exhibits134: Gilead Sciences Inc. - Key offerings; Exhibits135: GlaxoSmithKline Plc - Overview; Exhibits136: GlaxoSmithKline Plc - Business segments; Exhibits137: GlaxoSmithKline Plc - Key news; Exhibits138: GlaxoSmithKline Plc - Key offerings; Exhibits139: GlaxoSmithKline Plc - Segment focus; Exhibits140: Maruho Co. Ltd. - Overview; Exhibits141: Maruho Co. Ltd. - Product / Service; Exhibits142: Maruho Co. Ltd. - Key news; Exhibits143: Maruho Co. Ltd. - Key offerings; Exhibits144: Merck and Co. Inc. - Overview; Exhibits145: Merck and Co. Inc. - Business segments; Exhibits146: Merck and Co. Inc. - Key news; Exhibits147: Merck and Co. Inc. - Key offerings; Exhibits148: Merck and Co. Inc. - Segment focus; Exhibits149: Novartis AG - Overview; Exhibits150: Novartis AG - Business segments; Exhibits151: Novartis AG - Key news; Exhibits152: Novartis AG - Key offerings; Exhibits153: Novartis AG - Segment focus; Exhibits154: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits155: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits156: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits157: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits158: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits159: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits160: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits161: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits162: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits163: Viatris Inc. - Overview; Exhibits164: Viatris Inc. - Business segments; Exhibits165: Viatris Inc. - Key news; Exhibits166: Viatris Inc. - Key offerings; Exhibits167: Viatris Inc. - Segment focus; Exhibits168: Zydus Lifesciences Ltd. - Overview; Exhibits169: Zydus Lifesciences Ltd. - Business segments; Exhibits170: Zydus Lifesciences Ltd. - Key news; Exhibits171: Zydus Lifesciences Ltd. - Key offerings; Exhibits172: Zydus Lifesciences Ltd. - Segment focus; Exhibits173: Inclusions checklist; Exhibits174: Exclusions checklist; Exhibits175: Currency conversion rates for US$; Exhibits176: Research methodology; Exhibits177: Information sources; Exhibits178: Data validation; Exhibits179: Validation techniques employed for market sizing; Exhibits180: Data synthesis; Exhibits181: 360 degree market analysis; Exhibits182: List of abbreviations